CJC-1295 + Ipamorelin (5mg + 5mg) – Synergistic Research Blend

Dual-peptide system designed for advanced growth hormone pathway research.

CJC-1295 (no DAC) and Ipamorelin are frequently studied together for their complementary roles in growth hormone signaling. This carefully balanced blend combines a GHRH analog with a selective GHS peptide, allowing researchers to explore synergistic interactions across multiple regulatory pathways.

Our CJC-1295 + Ipamorelin (5mg + 5mg) is formulated for precision, consistency, and reliability—ideal for research models focused on controlled, pulsatile signaling and peptide synergy.

Blend Composition (Per Vial)

• CJC-1295 (no DAC): 5mg

• Ipamorelin: 5mg

  
  

Product Details

• Format: Lyophilized peptide blend

• Purity: ≥99% (HPLC tested)

• Appearance: Lyophilized white powder

• Storage: Store in a cool, dry place (refrigeration recommended after reconstitution)

  
  

Key Research Areas

• Pulsatile growth hormone signaling

• Multi-pathway endocrine interaction

• GHRH and ghrelin receptor synergy

• IGF-1 related pathway exploration

  
  

Why This Blend

• Combines two complementary mechanisms in one formulation

• Designed for synergistic pathway research

• Widely studied pairing in peptide research models

• Simplified dosing structure for consistency in experiments

  
  

Why Choose Biozone

• Precision-formulated peptide blends

• Third-party tested for purity and identity

• Sterile, sealed vials for maximum integrity

• Trusted by researchers seeking high-performance compounds

  
  

Important Notice

This product is intended for research purposes only. Not for human consumption, therapeutic, or diagnostic use.